Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Resources
Search
Monday, December 1, 2025
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
GE HealthCare Launches Advanced SIGNA MRI Technology
Samsung Bioepis Debuts Denosumab Biosimilars, OBODENCE™ and XBRYK™
Navitas Semiconductor and WT Microelectronics Expand Partnership
WISeKey, SEALSQ and WISeSat.Space Successfully Launch Their New Satellite Aboard SpaceX…
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Resources
Home
Tags
OBODENCE
OBODENCE
Biotechnology
Samsung Bioepis Debuts Denosumab Biosimilars, OBODENCE™ and XBRYK™
News Desk
-
December 1, 2025
Samsung Bioepis is set to launch OBODENCE™ (60 mg pre-filled syringe) and XBRYK™ (120 mg vial). These products are denosumab biosimilars from Prolia and...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
GE HealthCare Launches Advanced SIGNA MRI Technology
Samsung Bioepis Debuts Denosumab Biosimilars, OBODENCE™ and XBRYK™
Navitas Semiconductor and WT Microelectronics Expand Partnership
Load more
